QUEBEC CITY, QC, Sept. 10 /PRNewswire-FirstCall/ - Mr. Pierre Fitzgibbon, President and Chief Executive Officer of Atrium Innovations Inc. ("Atrium" or the "Company", TSX: ATB) today announced changes to the management structure of Atrium. These changes follow the decision by Mr. Richard Bordeleau, President of the Health & Nutrition Division, to resign his position in order to pursue news challenges. However, Mr. Bordeleau will continue to work with the Company as an external consultant on special projects.
"Richard played an important role in the development and growth of Atrium over the last few years. His talent and passion have greatly contributed to the success of the Company. Richard, after personal reflection, has decided to take on new challenges and we wish him the best. We are also very happy that we will be able to benefit from Richard's experience in his role as a consultant for Atrium", added Mr. Fitzgibbon.
Subsequent to Mr. Bordeleau's departure, Dr. Serge Yelle, Atrium's current Vice-President, Business Development is appointed Executive Vice-President, Health & Nutrition Division. Dr. Yelle's mandate will be to supervise the operations of the division. "Serge has demonstrated his vast know-how over the past few years in the development of Atrium not only in the identification of target companies, but also in the integration of acquired companies. He has done this most notably with Douglas Laboratories and more recently with Mucos. In his new position, Serge will exercise a greater leadership role in the development of the Company and will use his many talents that will be positive for the future of Atrium", stated Mr. Fitzgibbon.
Also, Mr. Jocelyn Harvey, Vice-President, Mergers & Acquisitions, will assume certain business development functions that were performed by Dr. Yelle. These functions include the identification and the qualification of acquisition targets.
Atrium Innovations Inc. is a recog
|SOURCE ATRIUM INNOVATIONS INC.|
Copyright©2007 PR Newswire.
All rights reserved